Bsenexus Terminal Open in Bsenexus App →
BSE: 500067 BLUESTARCO NSE

BLUE STAR LIMITED (500067) — Latest Corporate Announcements

₹1,564.9 ₹-5.10 (-0.32%)
Market Cap ₹32,173.24 Cr
P/E Ratio 63.00
52W Range ₹1432.3 – ₹2032.9
📅 Scheduled Board Meeting & Agenda
Meeting Date: 29-Oct-2026
Agenda / Purpose: Financial Results
Timeline: In 16 days
To consider and approve the financial results for the period ended September 30, 2026 Blue Star Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 Blue Star Ltd - 500067 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Blue Star Ltd - 500067 - Closure of Trading Window Blue Star Ltd - 500067 - Board Meeting Intimation for Consideration And Approval Of The Un-Audited Standalone And Consolidated Financial Results (With Limited Review Report) For The Second Quarter And Half Year Ended On September 30, 2026, Blue Star Ltd - 500067 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot Blue Star Ltd - 500067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Blue Star Ltd - 500067 - Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations') - Update Blue Star Ltd - 500067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation To consider and approve the financial results for the period ended Jun 30, 2026 To consider and approve the financial results for the period ended March 31, 2026 and dividend To consider and approve the financial results for the period ended December 31, 2025 To consider and approve the financial results for the period ended September 30, 2025 To consider and approve the financial results for the period ended March 31, 2025 and dividend To consider and approve the financial results for the period ended December 31, 2024 To consider and approve the Un-audited Standalone and Consolidated Financial Results (with limited review report) for the Second Quarter and Half Year ended September 30, 2024 To consider and approve the financial results for the period ended Jun 30, 2024 To consider and approve:1. The Audited Standalone and Consolidated Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2024, as required under Regulation 33(3) of the Listing Regulations; and2. Recommendation of final dividend for the year ended March 31, 2024, if any, on the equity shares of the Company. To consider and approve Un-Audited Standalone and Consolidated Financial Results (with Limited Review Report) for the Third Quarter and Nine Months ended December 31, 2023 To consider and approve the financial results for the period ended March 31, 2023 and dividend
Quarter / Period Meeting / Outcome Date Status Filing Details
Quarter Ended 30-Sep-2026 (Q2 FY27) 29-Oct-2026 Scheduled Upcoming To consider and approve the financial results for the period ended September 30, 2026
Quarter Ended 30-Jun-2026 (Q1 FY27) 06-Aug-2026 Declared To consider and approve the financial results for the period ended Jun 30, 2026
Year Ended 31-Mar-2026 (Q4 FY26) 06-May-2026 Declared To consider and approve the financial results for the period ended March 31, 2026 and dividend
Quarter Ended 31-Dec-2025 (Q3 FY26) 29-Jan-2026 Declared To consider and approve the financial results for the period ended December 31, 2025
Quarter Ended 30-Sep-2025 (Q2 FY26) 05-Nov-2025 Declared To consider and approve the financial results for the period ended September 30, 2025
Year Ended 31-Mar-2025 (Q4 FY25) 07-May-2025 Declared To consider and approve the financial results for the period ended March 31, 2025 and dividend
Quarter Ended 31-Dec-2024 (Q3 FY25) 29-Jan-2025 Declared To consider and approve the financial results for the period ended December 31, 2024
Quarter Ended 30-Sep-2024 (Q2 FY25) (STD & CONSOL) 06-Nov-2024 Declared To consider and approve the Un-audited Standalone and Consolidated Financial Results (with limited review report) for the Second Quarter and Half Year ended September 30, 2024
Quarter Ended 30-Jun-2024 (Q1 FY25) 06-Aug-2024 Declared To consider and approve the financial results for the period ended Jun 30, 2024
Year Ended 31-Mar-2024 (Q4 FY24) (STD & CONSOL) 02-May-2024 Declared To consider and approve:1. The Audited Standalone and Consolidated Financial Results of the Company for the Fourth Quarter and Financial Year ended March 31, 2024, as required under Regulation 33(3) of the Listing Regulations; and2. Recommendation of final dividend for the year ended March 31, 2024, if any, on the equity shares of the Company.
Quarter Ended 31-Dec-2023 (Q3 FY24) (STD & CONSOL) 30-Jan-2024 Declared To consider and approve Un-Audited Standalone and Consolidated Financial Results (with Limited Review Report) for the Third Quarter and Nine Months ended December 31, 2023
Year Ended 31-Mar-2023 (Q4 FY23) 04-May-2023 Declared To consider and approve the financial results for the period ended March 31, 2023 and dividend

What is the latest BSE announcement by BLUE STAR LIMITED?

The latest BSE disclosure by BLUE STAR LIMITED (BLUESTARCO), filed on 29-Oct-2026 , is: "To consider and approve the financial results for the period ended September 30, 2026". Bsenexus tracks every official filing for BLUE STAR LIMITED with AI-powered summaries on its announcements feed.

When is BLUE STAR LIMITED's next board meeting?

BLUE STAR LIMITED has a board meeting scheduled for 29-Oct-2026 (in 16 days) to consider: Financial Results.

When does BLUE STAR LIMITED declare quarterly results?

Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. BLUE STAR LIMITED's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.